Gastric Motility Disorder Drug Market Report

Europe Gastric Motility Disorder Drug Market Size, Status and Forecast 2014-2026

  • POSTDATE：Feb 04, 2020
  • PAGES：212
  • REPORT CODE：GMM460609
  • REPORT SUMMARY
  • TABLE OF CONTENTS

  • The Gastric Motility Disorder Drug market was valued at XX.0 Million US$ in 2018 and is projected to reach XX.0 Million US$ by 2026, at a CAGR (Compound Annual Growth Rate) of 3.7% during the forecast period. Focusing on the Europe market, this report analyzes the specific consumption structure, such as types and end users. In order to present the status of the circulation of this product in different Europe countries, this report covers top export and import countries to confirm the potential markets. Leading countries such as Germany, UK, France, Italy, Spain, Poland, Russia, Switzerland, Turkey, Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden), Benelux (Belgium, Netherlands, and Luxembourg), Baltic States (Estonia, Latvia, and Lithuania) and other countries, the market status and consumption potential of these countries are covered in the research, providing valuable opinions of strategic adjustments for existing groups and new entrants.

    The Snapshot of Europe Gastric Motility Disorder Drug Market Segmentations:

    By Player:

    • Concert Pharmaceuticals, Inc.

    • Helsinn Healthcare SA.

    • Helsinn Healthcare S.A.

    • ChironWells GmbH.

    • Theravance, Inc

    By Type:

    • Velusetrag

    • Ipamorelin

    • TD-8954

    • Others

    By End-User:

    • Hospital

    • Clinic

    • Home Use

    By Region:

    • Germany

    • UK

    • France

    • Italy

    • Spain

    • Poland

    • Russia

    • Switzerland

    • Turkey

    • Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden)

      • Denmark

      • Finland

      • Norway

      • Sweden

      • Iceland

    • Benelux (Belgium, Netherlands, and Luxembourg)

      • Belgium

      • Netherlands

      • Luxembourg

    • Baltic States (Estonia, Latvia, and Lithuania)

      • Estonia

      • Latvia

      • Lithuania

  • Table of Contents

    1 Report Overview

    • 1.1 Product Definition and Scope

    • 1.2 PEST (Political, Economic, Social and Technological) Analysis of Gastric Motility Disorder Drug Market

    • 1.3 Market Segment by Type

    • 1.3.1 Europe Gastric Motility Disorder Drug Market Size and Growth Rate of Velusetrag from 2014 to 2026

    • 1.3.2 Europe Gastric Motility Disorder Drug Market Size and Growth Rate of Ipamorelin from 2014 to 2026

    • 1.3.3 Europe Gastric Motility Disorder Drug Market Size and Growth Rate of TD-8954 from 2014 to 2026

    • 1.3.4 Europe Gastric Motility Disorder Drug Market Size and Growth Rate of Others from 2014 to 2026

    • 1.4 Market Segment by Application

    • 1.4.1 Europe Gastric Motility Disorder Drug Market Size and Growth Rate of Hospital from 2014 to 2026

    • 1.4.2 Europe Gastric Motility Disorder Drug Market Size and Growth Rate of Clinic from 2014 to 2026

    • 1.4.3 Europe Gastric Motility Disorder Drug Market Size and Growth Rate of Home Use from 2014 to 2026

    • 1.5 Market Segment by Regions

      • 1.5.1 Germany Gastric Motility Disorder Drug Market Size and Growth Rate from 2014 to 2026

      • 1.5.2 UK Gastric Motility Disorder Drug Market Size and Growth Rate from 2014 to 2026

      • 1.5.3 France Gastric Motility Disorder Drug Market Size and Growth Rate from 2014 to 2026

      • 1.5.4 Italy Gastric Motility Disorder Drug Market Size and Growth Rate from 2014 to 2026

      • 1.5.5 Spain Gastric Motility Disorder Drug Market Size and Growth Rate from 2014 to 2026

      • 1.5.6 Poland Gastric Motility Disorder Drug Market Size and Growth Rate from 2014 to 2026

      • 1.5.7 Russia Gastric Motility Disorder Drug Market Size and Growth Rate from 2014 to 2026

      • 1.5.8 Switzerland Gastric Motility Disorder Drug Market Size and Growth Rate from 2014 to 2026

      • 1.5.9 Turkey Gastric Motility Disorder Drug Market Size and Growth Rate from 2014 to 2026

      • 1.5.10 Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) Gastric Motility Disorder Drug Market Size and Growth Rate from 2014 to 2026

      • 1.5.11 Benelux (Belgium, Netherlands, and Luxembourg) Gastric Motility Disorder Drug Market Size and Growth Rate from 2014 to 2026

      • 1.5.12 Baltic States (Estonia, Latvia, and Lithuania) Gastric Motility Disorder Drug Market Size and Growth Rate from 2014 to 2026

    2 Market Trends and Competitive Landscape

    • 2.1 Market Trends and Dynamics

      • 2.1.1 Market Challenges and Restraints

      • 2.1.2 Market Opportunities and Potentials

      • 2.1.3 Mergers and Acquisitions

    • 2.2 Competitive Landscape Analysis

      • 2.2.1 Industrial Concentration Analysis

      • 2.2.2 Porter's Five Forces Analysis of the Industry

      • 2.2.3 SWOT Analysis for New Entrants

    3 Segmentation of Gastric Motility Disorder Drug Market by Types

    • 3.1 Products Development Trends of Different Types

    • 3.2 Commercial Products Types of Major Venders

    • 3.3 Competitive Landscape Analysis of Different Types

    • 3.4 Market Size of Gastric Motility Disorder Drug by Major Types

      • 3.4.1 Market Size and Growth Rate of Velusetrag

      • 3.4.2 Market Size and Growth Rate of Ipamorelin

      • 3.4.3 Market Size and Growth Rate of TD-8954

      • 3.4.4 Market Size and Growth Rate of Others

    4 Segmentation of Gastric Motility Disorder Drug Market by End-Users

    • 4.1 Downstream Client Analysis by End-Users

    • 4.2 Competitive Landscape Analysis of Different End-Users

    • 4.3 Market Potential Analysis of Different End-Users

    • 4.4 Market Size of Gastric Motility Disorder Drug by Major End-Users

      • 4.4.1 Market Size and Growth Rate of Gastric Motility Disorder Drug for Hospital

      • 4.4.2 Market Size and Growth Rate of Gastric Motility Disorder Drug for Clinic

      • 4.4.3 Market Size and Growth Rate of Gastric Motility Disorder Drug for Home Use

    5 Market Analysis by Major Regions

    • 5.1 Europe Gastric Motility Disorder Drug Production Analysis by Top Regions

    • 5.2 Europe Gastric Motility Disorder Drug Consumption Analysis by Top Regions

    • 5.3 Europe Gastric Motility Disorder Drug Production, Import, Consumption and Export Analysis by Regions

      • 5.3.1 Germany Gastric Motility Disorder Drug Production, Import, Consumption and Export Analysis

      • 5.3.2 UK Gastric Motility Disorder Drug Production, Import, Consumption and Export Analysis

      • 5.3.3 France Gastric Motility Disorder Drug Production, Import, Consumption and Export Analysis

      • 5.3.4 Italy Gastric Motility Disorder Drug Production, Import, Consumption and Export Analysis

      • 5.3.5 Spain Gastric Motility Disorder Drug Production, Import, Consumption and Export Analysis

      • 5.3.6 Poland Gastric Motility Disorder Drug Production, Import, Consumption and Export Analysis

      • 5.3.7 Russia Gastric Motility Disorder Drug Production, Import, Consumption and Export Analysis

      • 5.3.8 Switzerland Gastric Motility Disorder Drug Production, Import, Consumption and Export Analysis

      • 5.3.9 Turkey Gastric Motility Disorder Drug Production, Import, Consumption and Export Analysis

      • 5.3.10 Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) Gastric Motility Disorder Drug Production, Import, Consumption and Export Analysis

      • 5.3.11 Benelux (Belgium, Netherlands, and Luxembourg) Gastric Motility Disorder Drug Production, Import, Consumption and Export Analysis

      • 5.3.12 Baltic States (Estonia, Latvia, and Lithuania) Gastric Motility Disorder Drug Production, Import, Consumption and Export Analysis

    6 Product Circulation of Gastric Motility Disorder Drug Market among Top Countries

    • 6.1 Top 5 Export Countries in Gastric Motility Disorder Drug Market from 2014 to 2019

      • 6.1.1 Top 5 Export Countries’ Export Value Analysis in Gastric Motility Disorder Drug Market from 2014 to 2019

      • 6.1.2 Top 5 Export Countries’ Export Volume Analysis in Gastric Motility Disorder Drug Market from 2014 to 2019

    • 6.2 Top 5 Import Countries in Gastric Motility Disorder Drug Market from 2014 to 2019

      • 6.2.1 Top 5 Import Countries’ Import Value Analysis in Gastric Motility Disorder Drug Market from 2014 to 2019

      • 6.2.2 Top 5 Import Countries’ Import Volume Analysis in Gastric Motility Disorder Drug Market from 2014 to 2019

    • 6.3 Emerging Top 3 Export Countries Analysis

    • 6.4 Emerging Top 3 Import Countries Analysis

    7. Germany Gastric Motility Disorder Drug Landscape Analysis

    • 7.1 Germany Gastric Motility Disorder Drug Landscape Analysis by Major Types

    • 7.2 Germany Gastric Motility Disorder Drug Landscape Analysis by Major End-Users

    8. UK Gastric Motility Disorder Drug Landscape Analysis

    • 8.1 UK Gastric Motility Disorder Drug Landscape Analysis by Major Types

    • 8.2 UK Gastric Motility Disorder Drug Landscape Analysis by Major End-Users

    9. France Gastric Motility Disorder Drug Landscape Analysis

    • 9.1 France Gastric Motility Disorder Drug Landscape Analysis by Major Types

    • 9.2 France Gastric Motility Disorder Drug Landscape Analysis by Major End-Users

    10. Italy Gastric Motility Disorder Drug Landscape Analysis

    • 10.1 Italy Gastric Motility Disorder Drug Landscape Analysis by Major Types

    • 10.2 Italy Gastric Motility Disorder Drug Landscape Analysis by Major End-Users

    11. Spain Gastric Motility Disorder Drug Landscape Analysis

    • 11.1 Spain Gastric Motility Disorder Drug Landscape Analysis by Major Types

    • 11.2 Spain Gastric Motility Disorder Drug Landscape Analysis by Major End-Users

    12. Poland Gastric Motility Disorder Drug Landscape Analysis

    • 12.1 Poland Gastric Motility Disorder Drug Landscape Analysis by Major Types

    • 12.2 Poland Gastric Motility Disorder Drug Landscape Analysis by Major End-Users

    13. Russia Gastric Motility Disorder Drug Landscape Analysis

    • 13.1 Russia Gastric Motility Disorder Drug Landscape Analysis by Major Types

    • 13.2 Russia Gastric Motility Disorder Drug Landscape Analysis by Major End-Users

    14. Switzerland Gastric Motility Disorder Drug Landscape Analysis

    • 14.1 Switzerland Gastric Motility Disorder Drug Landscape Analysis by Major Types

    • 14.2 Switzerland Gastric Motility Disorder Drug Landscape Analysis by Major End-Users

    15. Turkey Gastric Motility Disorder Drug Landscape Analysis

    • 15.1 Turkey Gastric Motility Disorder Drug Landscape Analysis by Major Types

    • 15.2 Turkey Gastric Motility Disorder Drug Landscape Analysis by Major End-Users

    16. Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) Gastric Motility Disorder Drug Landscape Analysis

    • 16.1 Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) Gastric Motility Disorder Drug Landscape Analysis by Major Types

    • 16.2 Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) Gastric Motility Disorder Drug Landscape Analysis by Major End-Users

    • 16.3 Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) Gastric Motility Disorder Drug Landscape Analysis by Top Countries

      • 16.3.1 Denmark Gastric Motility Disorder Drug Market Volume and Growth Rate

      • 16.3.2 Finland Gastric Motility Disorder Drug Market Volume and Growth Rate

      • 16.3.3 Norway Gastric Motility Disorder Drug Market Volume and Growth Rate

      • 16.3.4 Sweden Gastric Motility Disorder Drug Market Volume and Growth Rate

      • 16.3.6 Iceland Gastric Motility Disorder Drug Market Volume and Growth Rate

    17 Benelux (Belgium, Netherlands, and Luxembourg) Gastric Motility Disorder Drug Landscape Analysis

    • 17.1 Benelux (Belgium, Netherlands, and Luxembourg) Gastric Motility Disorder Drug Landscape Analysis by Major Types

    • 17.2 Benelux (Belgium, Netherlands, and Luxembourg) Gastric Motility Disorder Drug Landscape Analysis by Major End-Users

    • 17.3 Benelux (Belgium, Netherlands, and Luxembourg) Gastric Motility Disorder Drug Landscape Analysis by Top Countries

      • 17.3.1 Belgium Gastric Motility Disorder Drug Market Volume and Growth Rate

      • 17.3.2 Netherlands Gastric Motility Disorder Drug Market Volume and Growth Rate

      • 17.3.3 Luxembourg Gastric Motility Disorder Drug Market Volume and Growth Rate

    18 Baltic States (Estonia, Latvia, and Lithuania) Gastric Motility Disorder Drug Landscape Analysis

    • 18.1 Baltic States (Estonia, Latvia, and Lithuania) Gastric Motility Disorder Drug Landscape Analysis by Major Types

    • 18.2 Baltic States (Estonia, Latvia, and Lithuania) Gastric Motility Disorder Drug Landscape Analysis by Major End-Users

    • 18.3 Baltic States (Estonia, Latvia, and Lithuania) Gastric Motility Disorder Drug Landscape Analysis by Top Countries

      • 18.3.1 Estonia Gastric Motility Disorder Drug Market Volume and Growth Rate

      • 18.3.2 Latvia Gastric Motility Disorder Drug Market Volume and Growth Rate

      • 18.3.3 Lithuania Gastric Motility Disorder Drug Market Volume and Growth Rate

    19 Major Players Profiles

    • 19.1 Concert Pharmaceuticals, Inc.

      • 19.1.1 Concert Pharmaceuticals, Inc. Company Profile and Development Status

      • 19.1.2 Market Performance

      • 19.1.3 Product and Service Introduction

    • 19.2 Helsinn Healthcare SA.

      • 19.2.1 Helsinn Healthcare SA. Company Profile and Development Status

      • 19.2.2 Market Performance

      • 19.2.3 Product and Service Introduction

    • 19.3 Helsinn Healthcare S.A.

      • 19.3.1 Helsinn Healthcare S.A. Company Profile and Development Status

      • 19.3.2 Market Performance

      • 19.3.3 Product and Service Introduction

    • 19.4 ChironWells GmbH.

      • 19.4.1 ChironWells GmbH. Company Profile and Development Status

      • 19.4.2 Market Performance

      • 19.4.3 Product and Service Introduction

    • 19.5 Theravance, Inc

      • 19.5.1 Theravance, Inc Company Profile and Development Status

      • 19.5.2 Market Performance

      • 19.5.3 Product and Service Introduction

    The List of Tables and Figures (Totals 70 Figures and 160 Tables)

    • Figure Product Picture

    • Figure Europe Gastric Motility Disorder Drug Market Size and Growth Rate of Velusetrag from 2014 to 2026

    • Figure Europe Gastric Motility Disorder Drug Market Size and Growth Rate of Ipamorelin from 2014 to 2026

    • Figure Europe Gastric Motility Disorder Drug Market Size and Growth Rate of TD-8954 from 2014 to 2026

    • Figure Europe Gastric Motility Disorder Drug Market Size and Growth Rate of Others from 2014 to 2026

    • Figure Europe Gastric Motility Disorder Drug Market Size and Growth Rate of Hospital from 2014 to 2026

    • Figure Europe Gastric Motility Disorder Drug Market Size and Growth Rate of Clinic from 2014 to 2026

    • Figure Europe Gastric Motility Disorder Drug Market Size and Growth Rate of Home Use from 2014 to 2026

    • Figure Germany Gastric Motility Disorder Drug Market Size and Growth Rate from 2014 to 2026

    • Figure UK Gastric Motility Disorder Drug Market Size and Growth Rate from 2014 to 2026

    • Figure France Gastric Motility Disorder Drug Market Size and Growth Rate from 2014 to 2026

    • Figure Italy Gastric Motility Disorder Drug Market Size and Growth Rate from 2014 to 2026

    • Figure Spain Gastric Motility Disorder Drug Market Size and Growth Rate from 2014 to 2026

    • Figure Poland Gastric Motility Disorder Drug Market Size and Growth Rate from 2014 to 2026

    • Figure Russia Gastric Motility Disorder Drug Market Size and Growth Rate from 2014 to 2026

    • Figure Switzerland Gastric Motility Disorder Drug Market Size and Growth Rate from 2014 to 2026

    • Figure Turkey Gastric Motility Disorder Drug Market Size and Growth Rate from 2014 to 2026

    • Figure Canada Gastric Motility Disorder Drug Market Size and Growth Rate from 2014 to 2026

    • Figure Mexico Gastric Motility Disorder Drug Market Size and Growth Rate from 2014 to 2026

    • Figure Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) Gastric Motility Disorder Drug Market Size and Growth Rate from 2014 to 2026

    • Figure Denmark Gastric Motility Disorder Drug Market Size and Growth Rate from 2014 to 2026

    • Figure Finland Gastric Motility Disorder Drug Market Size and Growth Rate from 2014 to 2026

    • Figure Norway Gastric Motility Disorder Drug Market Size and Growth Rate from 2014 to 2026

    • Figure Sweden Gastric Motility Disorder Drug Market Size and Growth Rate from 2014 to 2026

    • Figure Iceland Gastric Motility Disorder Drug Market Size and Growth Rate from 2014 to 2026

    • Figure Benelux (Belgium, Netherlands, and Luxembourg) Gastric Motility Disorder Drug Market Size and Growth Rate from 2014 to 2026

    • Figure Belgium Gastric Motility Disorder Drug Market Size and Growth Rate from 2014 to 2026

    • Figure Netherlands Gastric Motility Disorder Drug Market Size and Growth Rate from 2014 to 2026

    • Figure Luxembourg Gastric Motility Disorder Drug Market Size and Growth Rate from 2014 to 2026

    • Figure Baltic States (Estonia, Latvia, and Lithuania) Gastric Motility Disorder Drug Market Size and Growth Rate from 2014 to 2026

    • Figure Estonia Gastric Motility Disorder Drug Market Size and Growth Rate from 2014 to 2026

    • Figure Latvia Gastric Motility Disorder Drug Market Size and Growth Rate from 2014 to 2026

    • Figure Lithuania Gastric Motility Disorder Drug Market Size and Growth Rate from 2014 to 2026

    • Figure Development Trends and Industry Dynamics of Gastric Motility Disorder Drug Industry

    • Figure Market Challenges and Restraints

    • Figure Market Opportunities and Potentials

    • Table Mergers and Acquisition

    • Figure Market Share of TOP 6 Players from 2014 to 2019

    • Figure Porter's Five Forces Analysis

    • Figure New Entrant SWOT Analysis

    • Table Specifications of Different Types of Gastric Motility Disorder Drug

    • Figure Development Trends of Different Types

    • Table Commercial Products Types of Major Vendors

    • Figure Competitive Landscape Analysis of Different Types

    • Table Consumption of Gastric Motility Disorder Drug by Different Types from 2014 to 2026

    • Table Consumption Share of Gastric Motility Disorder Drug by Different Types from 2014 to 2026

    • Figure Market Size and Growth Rate of Velusetrag

    • Figure Market Size and Growth Rate of Ipamorelin

    • Figure Market Size and Growth Rate of TD-8954

    • Figure Market Size and Growth Rate of Others

    • Table Downstream Client Analysis by End-Users

    • Figure Competitive Landscape Analysis of Different End-Users

    • Table Market Potential Analysis of Different End-Users

    • Table Consumption of Gastric Motility Disorder Drug by Different End-Users from 2014 to 2026

    • Table Consumption Share of Gastric Motility Disorder Drug by Different End-Users from 2014 to 2026

    • Figure Market Size and Growth Rate of Hospital

    • Figure Market Size and Growth Rate of Clinic

    • Figure Market Size and Growth Rate of Home Use

    • Table Europe Gastric Motility Disorder Drug Production by Major Regions

    • Table Europe Gastric Motility Disorder Drug Production Share by Major Regions

    • Figure Europe Gastric Motility Disorder Drug Production Share by Major Countries and Regions in 2014

    • Table Europe Gastric Motility Disorder Drug Consumption by Major Regions

    • Table Europe Gastric Motility Disorder Drug Consumption Share by Major Regions

    • Table Germany Gastric Motility Disorder Drug Production, Import, Consumption and Export Analysis

    • Table UK Gastric Motility Disorder Drug Production, Import, Consumption and Export Analysis

    • Table France Gastric Motility Disorder Drug Production, Import, Consumption and Export Analysis

    • Table Italy Gastric Motility Disorder Drug Production, Import, Consumption and Export Analysis

    • Table Spain Gastric Motility Disorder Drug Production, Import, Consumption and Export Analysis

    • Table Poland Gastric Motility Disorder Drug Production, Import, Consumption and Export Analysis

    • Table Russia Gastric Motility Disorder Drug Production, Import, Consumption and Export Analysis

    • Table Switzerland Gastric Motility Disorder Drug Production, Import, Consumption and Export Analysis

    • Table Turkey Gastric Motility Disorder Drug Production, Import, Consumption and Export Analysis

    • Table Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) Gastric Motility Disorder Drug Production, Import, Consumption and Export Analysis

    • Table Benelux (Belgium, Netherlands, and Luxembourg) Gastric Motility Disorder Drug Production, Import, Consumption and Export Analysis

    • Table Baltic States (Estonia, Latvia, and Lithuania) Gastric Motility Disorder Drug Production, Import, Consumption and Export Analysis

    • Table Top 5 Export Countries' Export Value Analysis in Gastric Motility Disorder Drug Market from 2014 to 2019

    • Table Top 5 Export Countries' Export Volume Analysis in Gastric Motility Disorder Drug Market from 2014 to 2019

    • Table Top 5 Import Countries' Import Value Analysis in Gastric Motility Disorder Drug Market from 2014 to 2019

    • Table Top 5 Import Countries' Import Volume Analysis in Gastric Motility Disorder Drug Market from 2014 to 2019

    • Figure Emerging Top 3 Export Countries Analysis

    • Figure Emerging Top 3 Import Countries Analysis

    • Table Germany Gastric Motility Disorder Drug Consumption by Types from 2014 to 2026

    • Table Germany Gastric Motility Disorder Drug Consumption Share by Types from 2014 to 2026

    • Table Germany Gastric Motility Disorder Drug Consumption by End-Users from 2014 to 2026

    • Table Germany Gastric Motility Disorder Drug Consumption Share by End-Users from 2014 to 2026

    • Table UK Gastric Motility Disorder Drug Consumption by Types from 2014 to 2026

    • Table UK Gastric Motility Disorder Drug Consumption Share by Types from 2014 to 2026

    • Table UK Gastric Motility Disorder Drug Consumption by End-Users from 2014 to 2026

    • Table UK Gastric Motility Disorder Drug Consumption Share by End-Users from 2014 to 2026

    • Table France Gastric Motility Disorder Drug Consumption by Types from 2014 to 2026

    • Table France Gastric Motility Disorder Drug Consumption Share by Types from 2014 to 2026

    • Table France Gastric Motility Disorder Drug Consumption by End-Users from 2014 to 2026

    • Table France Gastric Motility Disorder Drug Consumption Share by End-Users from 2014 to 2026

    • Table Italy Gastric Motility Disorder Drug Consumption by Types from 2014 to 2026

    • Table Italy Gastric Motility Disorder Drug Consumption Share by Types from 2014 to 2026

    • Table Italy Gastric Motility Disorder Drug Consumption by End-Users from 2014 to 2026

    • Table Italy Gastric Motility Disorder Drug Consumption Share by End-Users from 2014 to 2026

    • Table Spain Gastric Motility Disorder Drug Consumption by Types from 2014 to 2026

    • Table Spain Gastric Motility Disorder Drug Consumption Share by Types from 2014 to 2026

    • Table Spain Gastric Motility Disorder Drug Consumption by End-Users from 2014 to 2026

    • Table Spain Gastric Motility Disorder Drug Consumption Share by End-Users from 2014 to 2026

    • Table Poland Gastric Motility Disorder Drug Consumption by Types from 2014 to 2026

    • Table Poland Gastric Motility Disorder Drug Consumption Share by Types from 2014 to 2026

    • Table Poland Gastric Motility Disorder Drug Consumption by End-Users from 2014 to 2026

    • Table Poland Gastric Motility Disorder Drug Consumption Share by End-Users from 2014 to 2026

    • Table Russia Gastric Motility Disorder Drug Consumption by Types from 2014 to 2026

    • Table Russia Gastric Motility Disorder Drug Consumption Share by Types from 2014 to 2026

    • Table Russia Gastric Motility Disorder Drug Consumption by End-Users from 2014 to 2026

    • Table Russia Gastric Motility Disorder Drug Consumption Share by End-Users from 2014 to 2026

    • Table Switzerland Gastric Motility Disorder Drug Consumption by Types from 2014 to 2026

    • Table Switzerland Gastric Motility Disorder Drug Consumption Share by Types from 2014 to 2026

    • Table Switzerland Gastric Motility Disorder Drug Consumption by End-Users from 2014 to 2026

    • Table Switzerland Gastric Motility Disorder Drug Consumption Share by End-Users from 2014 to 2026

    • Table Turkey Gastric Motility Disorder Drug Consumption by Types from 2014 to 2026

    • Table Turkey Gastric Motility Disorder Drug Consumption Share by Types from 2014 to 2026

    • Table Turkey Gastric Motility Disorder Drug Consumption by End-Users from 2014 to 2026

    • Table Turkey Gastric Motility Disorder Drug Consumption Share by End-Users from 2014 to 2026

    • Table Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) Gastric Motility Disorder Drug Consumption by Types from 2014 to 2026

    • Table Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) Gastric Motility Disorder Drug Consumption Share by Types from 2014 to 2026

    • Table Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) Gastric Motility Disorder Drug Consumption by End-Users from 2014 to 2026

    • Table Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) Gastric Motility Disorder Drug Consumption Share by End-Users from 2014 to 2026

    • Table Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) Gastric Motility Disorder Drug Consumption by Major Countries from 2014 to 2026

    • Table Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) Gastric Motility Disorder Drug Consumption Share by Major Countries from 2014 to 2026

    • Figure Denmark Gastric Motility Disorder Drug Market Volume and Growth Rate from 2014 to 2026

    • Figure Finland Gastric Motility Disorder Drug Market Volume and Growth Rate from 2014 to 2026

    • Figure Norway Gastric Motility Disorder Drug Market Volume and Growth Rate from 2014 to 2026

    • Figure Sweden Gastric Motility Disorder Drug Market Volume and Growth Rate from 2014 to 2026

    • Figure Iceland Gastric Motility Disorder Drug Market Volume and Growth Rate from 2014 to 2026

    • Table Benelux (Belgium, Netherlands, and Luxembourg) Gastric Motility Disorder Drug Consumption by Types from 2014 to 2026

    • Table Benelux (Belgium, Netherlands, and Luxembourg) Gastric Motility Disorder Drug Consumption Share by Types from 2014 to 2026

    • Table Benelux (Belgium, Netherlands, and Luxembourg) Gastric Motility Disorder Drug Consumption by End-Users from 2014 to 2026

    • Table Benelux (Belgium, Netherlands, and Luxembourg) Gastric Motility Disorder Drug Consumption Share by End-Users from 2014 to 2026

    • Table Benelux (Belgium, Netherlands, and Luxembourg) Gastric Motility Disorder Drug Consumption by Major Countries from 2014 to 2026

    • Table Benelux (Belgium, Netherlands, and Luxembourg) Gastric Motility Disorder Drug Consumption Share by Major Countries from 2014 to 2026

    • Figure Belgium Gastric Motility Disorder Drug Market Volume and Growth Rate from 2014 to 2026

    • Figure Netherlands Gastric Motility Disorder Drug Market Volume and Growth Rate from 2014 to 2026

    • Figure Luxembourg Gastric Motility Disorder Drug Market Volume and Growth Rate from 2014 to 2026

    • Table Baltic States (Estonia, Latvia, and Lithuania) Gastric Motility Disorder Drug Consumption by Types from 2014 to 2026

    • Table Baltic States (Estonia, Latvia, and Lithuania) Gastric Motility Disorder Drug Consumption Share by Types from 2014 to 2026

    • Table Baltic States (Estonia, Latvia, and Lithuania) Gastric Motility Disorder Drug Consumption by End-Users from 2014 to 2026

    • Table Baltic States (Estonia, Latvia, and Lithuania) Gastric Motility Disorder Drug Consumption Share by End-Users from 2014 to 2026

    • Table Baltic States (Estonia, Latvia, and Lithuania) Gastric Motility Disorder Drug Consumption by Major Countries from 2014 to 2026

    • Table Baltic States (Estonia, Latvia, and Lithuania) Gastric Motility Disorder Drug Consumption Share by Major Countries from 2014 to 2026

    • Figure Estonia Gastric Motility Disorder Drug Market Volume and Growth Rate from 2014 to 2026

    • Figure Latvia Gastric Motility Disorder Drug Market Volume and Growth Rate from 2014 to 2026

    • Figure Lithuania Countries Gastric Motility Disorder Drug Market Volume and Growth Rate from 2014 to 2026

    • Table Company Profile and Development Status of Concert Pharmaceuticals, Inc.

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Concert Pharmaceuticals, Inc.

    • Figure Sales and Growth Rate Analysis of Concert Pharmaceuticals, Inc.

    • Figure Revenue and Market Share Analysis of Concert Pharmaceuticals, Inc.

    • Table Product and Service Introduction of Concert Pharmaceuticals, Inc.

    • Table Company Profile and Development Status of Helsinn Healthcare SA.

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Helsinn Healthcare SA.

    • Figure Sales and Growth Rate Analysis of Helsinn Healthcare SA.

    • Figure Revenue and Market Share Analysis of Helsinn Healthcare SA.

    • Table Product and Service Introduction of Helsinn Healthcare SA.

    • Table Company Profile and Development Status of Helsinn Healthcare S.A.

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Helsinn Healthcare S.A.

    • Figure Sales and Growth Rate Analysis of Helsinn Healthcare S.A.

    • Figure Revenue and Market Share Analysis of Helsinn Healthcare S.A.

    • Table Product and Service Introduction of Helsinn Healthcare S.A.

    • Table Company Profile and Development Status of ChironWells GmbH.

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of ChironWells GmbH.

    • Figure Sales and Growth Rate Analysis of ChironWells GmbH.

    • Figure Revenue and Market Share Analysis of ChironWells GmbH.

    • Table Product and Service Introduction of ChironWells GmbH.

    • Table Company Profile and Development Status of Theravance, Inc

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Theravance, Inc

    • Figure Sales and Growth Rate Analysis of Theravance, Inc

    • Figure Revenue and Market Share Analysis of Theravance, Inc

    • Table Product and Service Introduction of Theravance, Inc

Report Version Choose

Report

BUY NOW

Our Customers

Beyond grateful for the confidence and support from all partners and customers.A win-win situation is our ultimate pursuit.

Beyond Consulting, Future is Feasible

We provide more professional and intelligent market reports to complement your business decisions.

CONTACT US